MBOT

Handel nachbörslich: .92 -0.0201 -2.14%

Microbot Medical Inc (MBOT)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose Aktiensplit

Schlusskurs vom Vortag:

24-Stunden-Volumen:

Relative Volume:

Marktkapitalisierung:

Nettoeinkommen (Verlust:

Netto-Cashflow:

1W Leistung:

1M Leistung:

6M Leistung:

1J Leistung:

1-Tages-Spanne:

1-Wochen-Bereich:

52-Wochen-Spanne:

Microbot Medical Inc Stock (MBOT) Company Profile

Microbot Medical Inc

Healthcare (1182)

908-938-5561

25 RECREATION PARK DR SUITE 108, HINGHAM, MA

@microbotmedical

Nächster Verdiensttermin

Neueste SEC-Einreichungen

MBOT's Discussions on Twitter

Microbot Medical Inc Stock (MBOT) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2020-01-13	Bestätigt	H.C. Wainwright	Buy
2019-12-24	Bestätigt	H.C. Wainwright	Buy
2018-01-31	Eingeleitet	Ladenburg Thalmann	Buy

Microbot Medical Inc Aktie (MBOT) Neueste Nachrichten

Finanzdaten der Microbot Medical Inc-Aktie (MBOT)

Microbot Medical Inc (MBOT)

Microbot Medical Inc Stock (MBOT) Company Profile

Microbot Medical Inc Stock (MBOT) Upgrades & Downgrades

Microbot Medical Inc Aktie (MBOT) Neueste Nachrichten

Microbot Medical Releases Investor Presentation Materials - TipRanks

Yoav Zvi Waizer Net Worth (2024) - GuruFocus.com

Microbot Medical LIBERTY System Trial Advancing Faster Than Expected - MPO-mag

Microbot Medical Announces the Successful Completion of its Pivotal Human Clinical Trial; Accelerates Go-to-Market Strategy to Prepare for Commercial Launch of LIBERTY® during 2Q 2025 - MSN

Microbot Medical Stock Rises After Completing ACCESS-PVI Trial - Yahoo Finance

Market Update: Microbot Medical Inc (MBOT) Sees Positive Movement, Closing at 0.96 - The Dwinnex

Microbot Medical completes key clinical trial, eyes FDA submission By Investing.com - Investing.com Australia

Microbot eyes FDA application for surgical robot after completing pivotal trial - Medical Device Network

Microbot Medical completes enrolment for ACCESS-PVI clinical trial - Vascular News

Microbot Medical completes key clinical trial, eyes FDA submission - Investing.com

Microbot Medical Advances Towards FDA Submission and Market Entry - TipRanks

Microbot Medical Announces the Successful Completion of its - GlobeNewswire

Microbot Medical faces Nasdaq delisting over share price - Investing.com India

Microbot Medical faces Nasdaq delisting over share price By Investing.com - Investing.com South Africa

Microbot Medical nears end of pivotal clinical trial - Investing.com

Microbot shifts pivotal trial up a gear with completion expected ahead of schedule - Medical Device Network

Microbot Medical Nears FDA Submission with Clinical Advances - TipRanks

Microbot Medical Inc. Accelerates Patient Enrollment of Its Pivotal Human Clinical Trial - Marketscreener.com

Microbot Medical Accelerates Patient Enrollment of its Pivotal Human Clinical Trial; Expects to - The Bakersfield Californian

Microbot Medical Accelerates Patient Enrollment of its - GlobeNewswire

Microbot Medical Accelerates Patient Enrollment of its Pivotal Human Clinical Trial; Expects to Complete the Trial Earlier Than Anticipated as 80% of Patients Have Completed Follow up - StockTitan

Epoch Investment Partners Inc. Decreases Stake in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) - MarketBeat

MicroAlgo receives Nasdaq minimum bid price warning - Investing.com

MicroAlgo Faces Nasdaq Minimum Price Warning - TipRanks

MLGO’s Market Seesaw: Yearly Gains & Recent Declines – What to Expect? - The InvestChronicle

Quarterly Snapshot: Quick and Current Ratios for MicroAlgo Inc (MLGO) - The Dwinnex

The Wild Robot giveaway - Lyles Movie Files

Pedro Pascal and Lupita Nyong’o starrer The Wild Robot to release in Indian theatres on October 18 - Bollywood Hungama

Win Advance Screening Passes to THE WILD ROBOT in Florida - FlickDirect, Your Premiere Source For Movies And Entertainment!

Creo Medical Partners with Micro-Tech for Strategic Growth - TipRanks

Microbot Medical (NASDAQ:MBOT) & Treace Medical Concepts (NASDAQ:TMCI) Head-To-Head Review - Defense World

OrbiMed executives purchase $12 million of MBX Biosciences stock By Investing.com - Investing.com UK

The Wild Robot- Chicago – Advance Screening - The Movie Blog

Microbot Medical Advances in Endovascular Robotic Trials - TipRanks

Microbot Medical Announces the Successful Enrollment of 50% - GlobeNewswire

Microbot Medical Inc. Announces the Successful Enrollment of 50% of the Patients in its Pivotal Human Clinical Trial for the LIBERTY Endovascular Robotic Surgical System - Marketscreener.com

Microbot Medical Announces the Successful Enrollment of 50% of the Patients in its Pivotal Human Clinical Trial for the LIBERTY Endovascular Robotic Surgical System - Yahoo Finance

Microbot Medical Stock Is Moving Higher: What's Going On? - MSN

Microbot Medical Shares Investor Presentation Update - TipRanks

Trial Enrollment For LIBERTY Robotic Surgical System Reaches Midpoint - MPO-mag

MBOT stock touches 52-week low at $0.85 amid market challenges - Investing.com

Market Resilience: Microbot Medical Inc (MBOT) Finishes Weak at 0.88, Down -4.35 - The Dwinnex

THINK Surgical scoops additional FDA 510(k) clearance on Tmini surgical robot - Medical Device Network

Microbot Medical, Emory University To Consider LIBERTY Robotic System Partnership - MPO-mag

Microbot Medical advances Liberty Robotic System telesurgery innovation - Yahoo Finance

Microbot Medical, Emory University to Consider LIBERTY Robotic System Partnership - MPO-mag

Microbot Medical (MBOT) Inks New Phase 2 Agreement for LIBERTY - MSN

Microbot advances Liberty robotic system to next phase of remote telesurgery evaluation - Medical Device Network

Microbot Medical advances telesurgery with new phase - Investing.com India

Microbot Medical advances telesurgery with new phase By Investing.com - Investing.com Canada

Examining MBOT’s book value per share for the latest quarter - US Post News

Finanzdaten der Microbot Medical Inc-Aktie (MBOT)

Umsatz

Nettogewinn

Free Cashflow

ENV

Ähnlich wie MBOT